Our previous studies demonstrated that kavalactones inhibited mRNA expression of PSA and TMPRESS2, two key AR target genes, in LNCaP cells and tumor tissues of prostate cancer PDX model[9]. This evidence concerns the gene AR and prostate carcinoma.